2022 Scientific Sessions

Great Debates/Controversies

Debate: Valve Durability in Aortic Stenosis – TAVR First! Should TAVR Always Be the First Valve?
James E. Harvey, M.D., FSCAI, WellSpan York Hospital, Red Lion, PA
View Recording Download Slides
Debate: Valve Durability in Aortic Stenosis – The Data Proves SAVR Is the First Option
Gilbert Tang, MD, MBA, FSCAI, Mount Sinai Health System, New York, NY
View Recording
Debate: Role of TEER in Treatment of MR – TEER Performs Well for All MR: Intermediate Risk, Here We Come!
Saibal Kar, M.D., FSCAI, Los Robles Hospital, Los Angeles, CA
View Recording Download Slides
Debate: Role of TEER in Treatment of MR—TEER Data for All Is Unclear: TEER Should Be Used Only for Those at Prohibitive Risk for Surgery
Michael J. Rinaldi, M.D., FSCAI, Sanger Heart & Vascular Institute, Charlotte, NC
View Recording Download Slides
See more of: Structural Heart Disease
<< Previous Session | Next Session >>